Home > Journals > The Quarterly Journal of Nuclear Medicine and Molecular Imaging > Past Issues > The Quarterly Journal of Nuclear Medicine and Molecular Imaging 2021 December;65(4) > The Quarterly Journal of Nuclear Medicine and Molecular Imaging 2021 December;65(4):371-5

CURRENT ISSUE
 

JOURNAL TOOLS

Publishing options
eTOC
To subscribe
Submit an article
Recommend to your librarian
 

ARTICLE TOOLS

Publication history
Reprints
Permissions
Cite this article as
Share

 

REVIEW  THERAGNOSTICS APPLICATIONS AND CHALLENGES 

The Quarterly Journal of Nuclear Medicine and Molecular Imaging 2021 December;65(4):371-5

DOI: 10.23736/S1824-4785.21.03417-8

Copyright © 2021 EDIZIONI MINERVA MEDICA

language: English

Challenges in theragnostics

Laura EVANGELISTA 1 , Diego CECCHIN 1, Jolanta KUNIKOWSKA 2

1 Unit of Nuclear Medicine, Department of Medicine (DIMED), Padua University Hospital, Padua, Italy; 2 Department of Nuclear Medicine, Medical University of Warsaw, Warsaw, Poland



Precision medicine (or personalized medicine) is an intriguing, and still involving part of modern medicine. Theragnostics is a combination of therapies and diagnostics targeting pathophysiological processes at molecular level using radiopharmaceuticals. It is a valuable resource in efforts to implement precision medicine in clinical practice, but the theragnostic era poses an abundance of challenges. The aim of the present paper study was to analyze some of these challenges in the field of theragnostics, irrespective of their clinical applications. Three experts in this field discussed the balance between the demand, the costs of theragnostics, the need of appropriate infrastructures, and the opportunities for new developments in this area.


KEY WORDS: Precision medicine; Nuclear medicine; Education; Financial support; Interdisciplinary studies

top of page